vesnarinone has been researched along with Cardiomyopathy, Congestive in 9 studies
Excerpt | Relevance | Reference |
---|---|---|
"Myocarditis is thought to be caused by various viruses, and accumulating evidence links viral myocarditis with the eventual development of dilated cardiomyopathy." | 2.39 | Cytokines in myocarditis and cardiomyopathies. ( Matsumori, A, 1996) |
"Xamoterol was highly effective in patients with atrial fibrillation who not only had excessive tachycardia during exercise but marked bradycardia at night." | 1.28 | [How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias]. ( Fukuda, K; Handa, S; Kawamura, Y; Nakamura, Y; Ogawa, S, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertolet, BD | 1 |
White, BG | 1 |
Pepine, CJ | 1 |
O'Connell, JB | 1 |
Moore, CK | 1 |
Waterer, HC | 1 |
Matsumori, A | 2 |
Sasayama, S | 2 |
Kurabayashi, M | 1 |
Yamaoki, K | 1 |
Yazaki, Y | 1 |
Feldman, AM | 2 |
Baughman, KL | 2 |
Lee, WK | 1 |
Gottlieb, SH | 1 |
Weiss, JL | 1 |
Becker, LC | 2 |
Strobeck, JE | 1 |
Fukuda, K | 1 |
Handa, S | 1 |
Ogawa, S | 1 |
Nakamura, Y | 1 |
Kawamura, Y | 1 |
Llewellyn, MP | 1 |
Inoue, M | 1 |
Asanoi, H | 1 |
Kodama, K | 1 |
Hori, M | 1 |
Sakurai, T | 1 |
Kawai, C | 1 |
4 reviews available for vesnarinone and Cardiomyopathy, Congestive
Article | Year |
---|---|
Treatment of end stage dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Transplantation; Hum | 1994 |
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; B | 1995 |
Cytokines in myocarditis and cardiomyopathies.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cytokines; Heart Injuries; Hepatitis C; Humans | 1996 |
[Dilated cardiomyopathy in children].
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cardiotonic Agents; Child; Child, | 1996 |
2 trials available for vesnarinone and Cardiomyopathy, Congestive
Article | Year |
---|---|
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardioton | 1991 |
Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Trials as Topic; Exercise Test; Female; | 1988 |
3 other studies available for vesnarinone and Cardiomyopathy, Congestive
Article | Year |
---|---|
Neutropenia occurring during treatment with vesnarinone (OPC-8212).
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Clinical Trials as Topic; Europe; Female; Granulocyte C | 1994 |
[How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Car | 1990 |
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coro | 1986 |